May
2002
Dr. Steven J. Slagle -- May 15


Presenting his experiences using the patented natural immune booster and modulator, Transfer Factor and Transfer Factor Plus. He has seen over 300 individuals take these products for hepatitis C, cancer, fibromyalgia, chronic fatigue syndrome, asthma, and many other difficult diseases.

Upcoming Agendas:

Meeting Agenda:
6:30 p.m. (sharp) - Theme Song: I Will Survive
6:35 - 6:45 announcements
6:45 - 7:00 introduction of leadership from The Effort
7:00 - 8:15 Dr. Steven J. Slagle
8:15 - 8:45 (or earlier) questions/answers 'til we adjourn

June 18 -- To Be Announced
July 16 -- To Be Announced
August 20 -- To Be Announced
September 17 -- Dr. Gish

I Will Survive is affiliated with THE EFFORT:


In order to become able to accept tax deductible donations, I Will Survive has affiliated itself with THE EFFORT, Inc., which provides a licensed and certified treatment program for substance abuse and addiction. Donation checks should be made payable to "I Will Survive, The Effort".

More News

Our Meetings: Our Meetings: 3rd Wednesday of every month; at SCC (Sutter Cancer Center) classrooms 3&4 , 2800 L St (kitty corner across from the 2-story parking structure at 28th & L St. and across L St. from Sutter Hospital)
Contact Us: Phone number: (need volunteer)
Our Web Site> www.sacmall.net/transplant/hepc.html
Email
: dck@innercite.com (include "I Will Survive" in subject line or your message might be delected before being read).

If you want to be included on our mailing/emailing list and you can afford to include a donation, make it to "I Will Survive, The Effort", P.O. Bx 2180, Loomis, CA 95650 for:
$24 if you want the Newsletter by U.S. mail
$15 if you get the Newsletter from the website (if you wish, each month we'll email a link to you)
$ 0 if, right now, you can't afford to pay dues. In which case "I Will Survive" will mail monthly Newsletters to you. Please contribute to the "Donations" Box at the meetings as you are able.

From the May 2002 HCV Advocate:
..The results of the second phase 3 trials of Pegasys with ribavirin were announced at the EASL (European Association for the Study of the Liver) Conference. Those results are as follows (SVR = Sustained Virological Response=virus still undetectable 6 months minimum after withdrawal from treatment):
All Patients Overall SVR
Non-Cirrhotics Overall SVR
Cirrhotic Overall SVR
Genotype 1 Overall SVR
Genotype 1, high viral load SVR
Genotype 1, low viral load SVR
Genotype Non-1 Overall SVR
61%
65%
50%
51%
46%
61%
78%
It was found that for patients with genotype 1, 48 weeks of treatment is needed with standard ribavirin doses of 1000/1200mg; efficacy falls if either the duration of therapy is reduced or the ribavirin dose is reduced. In genotype non-1 patients, only 24 weeks of treatment is needed with a low dose of ribavirin (800mg).
...An article about transmission of hepatitis C reviews the variety of ways that the virus can be transmitted. They are by blood-to-blood contact and, more rarely, by sexual activity or from mother to child. Specifically mentioned were shared injection drug equipment (needles and syringes, also cookers, cotton filters, ties, and water used to dissolve drugs or rinse syringes) and shared non-injection drug equipment (cocaine straws and crack pipes). Also of note, tattooing and body piercing, manicure scissors, files, and nail clippers, and barber tools such as razors and hair clippers. Some personal grooming and beauty items were mentioned: nail files, razors, toothbrushes, pierced earrings and other jewelry. Another potential method of blood-borne HCV transmission is through contact with blood or body fluids in a health-care setting by accidental "sticks", and bandages that are not properly discarded. Transmission of HCV from mothers to babies before or during birth (perinatal or vertical transmission) is uncommon, occurring in an estimated 5% of cases. Perinatal transmission is most likely when the mother has a high level of HCV in her blood.


If you have no money or insurance call:
Sacramento Clinical Trials
Schering's Commitment to Care 1-800-521-7157
Infergen's Safety Net Program 1-888-508-8088
Roche's Patient Assistance 1-800-443-6676
Dr. Gish, et al, call: Pacific Hepatology, (916) 443-0503
Dr. Pimstone UCD Med Center, (916) 734-1557

Dr. Rossaro UCD Med Cntr, call: Katherine Suggett (916) 734-8696



Return to Hep C Support Page

Web Page Design and Hosting by
SacMall.Net - Sacramento, CA